CryoPort (CYRX) Competitors

Evotec (NASDAQ:EVO) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Do analysts prefer EVO or CYRX?

Evotec presently has a consensus target price of $5.93, indicating a potential upside of 41.44%. CryoPort has a consensus target price of $11.00, indicating a potential upside of 43.98%. Given CryoPort's stronger consensus rating and higher probable upside, analysts plainly believe CryoPort is more favorable than Evotec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evotec	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
CryoPort	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Which has preferable earnings & valuation, EVO or CYRX?

CryoPort has lower revenue, but higher earnings than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evotec	$862.40M	1.73	-$212.18M	N/A	N/A
CryoPort	$228.38M	1.68	-$114.76M	-$2.34	-3.26

Does the media favor EVO or CYRX?

In the previous week, CryoPort had 1 more articles in the media than Evotec. MarketBeat recorded 3 mentions for CryoPort and 2 mentions for Evotec. Evotec's average media sentiment score of 1.13 beat CryoPort's score of 0.81 indicating that Evotec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evotec	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CryoPort	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, EVO or CYRX?

Evotec has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.89, indicating that its stock price is 89% more volatile than the S&P 500.

Do insiders & institutionals believe in EVO or CYRX?

5.8% of Evotec shares are held by institutional investors. Comparatively, 92.9% of CryoPort shares are held by institutional investors. 1.0% of Evotec shares are held by company insiders. Comparatively, 10.0% of CryoPort shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is EVO or CYRX more profitable?

Evotec has a net margin of -26.34% compared to CryoPort's net margin of -50.15%. CryoPort's return on equity of -11.03% beat Evotec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evotec	-26.34%	-21.51%	-10.54%
CryoPort	-50.15%	-11.03%	-5.54%

Summary

CryoPort beats Evotec on 10 of the 14 factors compared between the two stocks.